Dr Cuiqing Liu

PhD (2006-2008), Department of Physiology, Fudan University Shanghai Medical School and Department of Physiology, Chinese University of Hong Kong

Currently the Associate Professor at Hangzhou Normal University

• Liu C & Huang Y (2016) Chinese herbal medicine on cardiovascular diseases and the mechanisms of action. Frontiers in Pharmacology 7: Article 469. 01 December 2016 | http://dx.doi.org/10.3389/fphar.2016.00469

• Liu CQ, Wong SL, Leung FP, Tian XY, Lau CW, Lu LM, Yao X, Chen ZY, T Yao & Huang Y (2010) Prostanoid TP receptor-mediated impairment of cyclic AMP-dependent vasorelaxation is reversed by phosphodiesterase inhibitors. European Journal of Pharmacology 632(1):45-51.

• Liu CQ, Leung FP, Wong SL, Lau CW, Wong WT, Lu L, Yao X, Yao T & Huang Y (2009) Thromboxane prostanoid receptor activation impairs endothelial nitric oxide-dependent vasorelaxations: the role of Rho kinase. Biochemical Pharmacology 78(4):374-381.

• Liu CQ, Leung FP, Lee WY, Lau CW, Yao Y, Lu Limin & Huang Y (2008) Prevention of nitroglycerin tolerance in vitro by T0156, a selective phosphodiesterase type 5 inhibitor. European Journal of Pharmacology 590(1-3):250-254.